ストックスクリーナーアプリを入手
104.84
2.91%
-3.14
プレマーケット:
91.70
-13.14
-12.53%
前日終値:
$107.98
開ける：
$107
24時間の取引高:
1.07M
Relative Volume:
1.24
時価総額：
$7.13B
収益：
$1.50B
当期純損益:
$427.61M
株価収益率:
17.44
EPS:
6.01
ネットキャッシュフロー:
$423.98M
1週間 パフォーマンス:
+0.85%
1か月 パフォーマンス:
+15.31%
6か月 パフォーマンス:
+14.99%
1年 パフォーマンス:
+38.84%
1日の値動き範囲:
$104.40
$108.91
1週間の範囲:
$101.53
$108.91
52週間の値動き範囲:
$74.28
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
名前
Lantheus Holdings Inc
セクター
電話
978 671-8001
住所
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
LNTH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
104.84 | 7.13B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
149.87 | 69.33B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.17 | 48.09B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.67 | 46.34B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.12 | 18.47B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
295.02 | 13.57B | 2.76B | 1.11B | 898.10M | 22.77 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-18 | 開始されました | Goldman | Buy |
| 2024-09-03 | 開始されました | Redburn Atlantic | Buy |
| 2024-07-10 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2023-12-18 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | 開始されました | TD Cowen | Outperform |
| 2023-09-29 | 開始されました | William Blair | Outperform |
| 2023-03-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-11-30 | 開始されました | SVB Leerink | Outperform |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-05-09 | 開始されました | B. Riley Securities | Buy |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2021-02-01 | 開始されました | SVB Leerink | Outperform |
| 2020-06-29 | 再開されました | Jefferies | Buy |
| 2019-08-16 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2016-09-23 | 再開されました | Credit Suisse | Neutral |
| 2016-02-24 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2015-12-11 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | 開始されました | Credit Suisse | Outperform |
| 2015-07-20 | 開始されました | Jefferies | Buy |
| 2015-07-20 | 開始されました | RBC Capital Mkts | Outperform |
| 2015-07-20 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-20 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Lantheus Holdings Inc (LNTH) 最新ニュース
Lantheus Holdings: Q1 Earnings Snapshot - The Washington Post
Lantheus Q1 2025 slides: Revenue flat, EPS down as company focuses on acquisitions - Investing.com India
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Lantheus announces plans to divest SPECT imaging business - Radiology Business
Lantheus to sell SPECT Business to SHINE Technologies - Seeking Alpha
Lantheus Announces Sale of SPECT Business to SHINE Technologies - The Manila Times
Lantheus divests SPECT business to SHINE Technologies - Investing.com
SHINE Technologies Announces Plan to Acquire Lantheus' SPECT Division, Expanding Market Reach and Leadership in Nuclear Medicine - Yahoo Finance
Lantheus Earnings: What To Look For From LNTH - Yahoo Finance
Lantheus Holdings (NasdaqGM:LNTH) Advances Alzheimer's PET Diagnostic With Successful Trial Results - Yahoo Finance
Lantheus (LNTH) Advances Alzheimer's Imaging Agent MK-6240 - GuruFocus
Lantheus announces pivotal trial win for Alzheimer’s imaging agent - Seeking Alpha
Fund Update: BRIDGES INVESTMENT MANAGEMENT INC added 13,439 shares of LANTHEUS HOLDINGS ($LNTH) to their portfolio - Nasdaq
Lantheus Says Alzheimer's Disease Radiodiagnostic MK-6240 Meets Primary Endpoints in Two Trials - marketscreener.com
Lantheus (LNTH) Achieves Key Milestones with MK-6240 Radiodiagno - GuruFocus
Lantheus to file NDA for Alzheimer’s diagnostic tool By Investing.com - Investing.com India
Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 M - GuruFocus
Lantheus to file NDA for Alzheimer’s diagnostic tool - Investing.com Australia
Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies - The Manila Times
Lantheus Holdings, Inc. Announces Positive Results for MK-6240, a Potential Alzheimer's Disease Diagnostic Tool - Nasdaq
Lantheus Announces Alzheimer's Disease Radiodiagnostic Mk-6240 Meets Co-Primary Endpoints In Two Pivotal Studies - marketscreener.com
Lantheus's Revolutionary Alzheimer's Brain Scan Hits Major Milestone, FDA Filing Next - Stock Titan
Lantheus Holdings, Inc. (LNTH): Among Stocks with Consistent Growth to Buy Now - MSN
Breaking News: FDA Approves a Highly Sensitive Prostate Cancer Imaging Agent - PCF | Prostate Cancer Foundation
Lantheus Holdings Inc (LNTH) Shares Gap Down to $100.08 on Apr 2 - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
11 Stocks with Consistent Growth to Buy Now - Insider Monkey
Lantheus to Host First Quarter 2025 Earnings Conference Call and - GuruFocus
Lantheus Holdings, Inc. Announces Conference Call to Discuss Q1 2025 Financial Results - Nasdaq
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time - The Manila Times
Lantheus Q1 2025 Earnings Call: How to Join the May 7 Investor Presentation - Stock Titan
Lantheus Holdings, Inc. (NASDAQ:LNTH) Shares Could Be 44% Below Their Intrinsic Value Estimate - simplywall.st
In tough environment, Lantheus has cash and plans to use it - The Business Journals
(LNTH) Proactive Strategies - news.stocktradersdaily.com
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights By Investing.com - Investing.com India
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - The Globe and Mail
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights - Investing.com India
LNTH Quantitative Stock Analysis - Nasdaq
3 Leading Stocks Estimated To Be Up To 45.9% Below Intrinsic Value - Yahoo Finance
Lantheus Closes Evergreen Theragnostics Acquisition - MarketScreener
Lantheus Completes Acquisition of Evergreen Theragnostics - TipRanks
Lantheus completes acquisition of Evergreen Theragnostics - TipRanks
Lantheus bolsters radiopharmaceutical portfolio with acquisition - Investing.com
Major Radiopharmaceutical Deal: Lantheus Acquires Evergreen, Gains Revenue-Generating Assets - Stock Titan
How To Trade (LNTH) - news.stocktradersdaily.com
Lobbying Update: $420,000 of LANTHEUS HOLDINGS INC. lobbying was just disclosed - Nasdaq
Q4 Earnings Review: Medical Devices & SuppliesImaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC) - The Globe and Mail
CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment - Yahoo Finance
Returns On Capital Are A Standout For Lantheus Holdings (NASDAQ:LNTH) - Yahoo Finance
Lantheus Holdings: One Blockbuster, Evolving Pipeline (NASDAQ:LNTH) - Seeking Alpha
Are Strong Financial Prospects The Force That Is Driving The Momentum In Lantheus Holdings, Inc.'s NASDAQ:LNTH) Stock? - simplywall.st
Lantheus Holdings Inc (LNTH) 財務データ
収益
当期純利益
現金流量
EPS
1.45%
8.36%
大文字化:
|
ボリューム (24 時間):